TD Cowen Maintains Buy on Thermo Fisher Scientific, Raises Price Target to $760

10/13/2026
Impact: 75
Healthcare

TD Cowen analyst Dan Brennan has maintained a Buy rating on Thermo Fisher Scientific (NYSE: TMO) and increased the price target from $675 to $760. This adjustment reflects a positive outlook for the company in the market.

AI summary, not financial advice

Share: